Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

NCT01763606 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cancer Patients First-ever Acute Ischemic Stroke

Interventions

DRUG: Enoxaparin
DRUG: Aspirin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]